Joseph Nano Cardiovascular Disease, Uncategorized

Heart‑rate variability and mental health: big evidence map finds signals—but not definitive proof

An umbrella review of 71 meta‑analyses reports that people with certain mental health conditions tend to have lower heart‑rate variability (HRV)—a measure of the heart’s beat‑to‑beat adaptability—yet the overall evidence remains limited. Strongest signals (still only “suggestive”) appeared for dementia, PTSD, schizophrenia, and functional/somatic symptom disorders. For depression, anxiety, bipolar disorder, insomnia, autism, and alcohol use disorder, findings were weaker. Treatments like rTMS and psychotherapy may improve some HRV measures, while antipsychotics can reduce HRV.

What’s new

Researchers combined 21 systematic reviews covering 19 diagnoses (53 case‑control meta‑analyses) and 8 treatment types (18 meta‑analyses), spanning 442 primary studies and ~34,600 participants. About half (47%) of case‑control analyses showed a statistically significant HRV difference, but only 7 of 53 (13%) reached a “suggestive” evidence tier—and none met the stricter “highly suggestive” or “convincing” thresholds. Most analyses showed high between‑study variability and signs of small‑study effects, meaning results weren’t consistently robust across larger or future studies.

By diagnosis (high‑level takeaways)

  • Suggestive evidence of lower HRV: dementia, PTSD, schizophrenia, somatic symptom disorders and functional somatic syndromes.
  • Below‑suggestive evidence: major depression, generalized anxiety, bipolar disorder, insomnia, autism, alcohol use disorder, among others.
  • Patterns differed by HRV metric (e.g., RMSSD, HF, SDNN, LF/HF); no two disorders shared an identical HRV profile.

What about treatments?

Across 18 pooled analyses, 5 (28%) showed weak evidence of change:

  • rTMS: ↑ RMSSD and ↓ LF/HF (favorable shifts).
  • Psychotherapy for depression: ↑ HF.
  • Physiotherapy for depression: ↓ LF.
  • Antipsychotics: overall decrease in HRV, reinforcing the need to monitor cardiac risk.Most treatment analyses found no clear HRV change, and several had notable heterogeneity.

Why it matters

HRV is often touted as a window into stress and nervous‑system balance. This review suggests HRV can be a useful piece of the puzzle—especially in PTSD, schizophrenia, and functional disorders—but it’s not ready as a stand‑alone diagnostic or universal treatment marker. The authors urge larger, better‑standardized studies, caution that the popular LF/HF ratio is controversial, and note that factors like age, medication, sleep, fitness, and illness severity can all sway HRV.

Bottom line for readers

  • Think of HRV as supporting context, not a diagnosis.
  • Any HRV discussion should sit alongside clinical evaluation, symptoms, and (when relevant) cardiac monitoring—especially if taking medications that affect the heart.

Source: Wang Z, Zou Y, Liu J, Peng W, Li M, Zou Z. “Heart rate variability in mental disorders: an umbrella review of meta‑analyses.” Translational Psychiatry. 2025. doi: 10.1038/s41398-025-03339-x.